Yizhi Zhan

897 total citations
18 papers, 621 citations indexed

About

Yizhi Zhan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yizhi Zhan has authored 18 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yizhi Zhan's work include Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Yizhi Zhan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Yizhi Zhan collaborates with scholars based in China and United States. Yizhi Zhan's co-authors include Yi� Ding, Yuan Fang, Yongsheng Li, Haijun Deng, Zhiyong Shen, Xiaochuang Feng, Keli Chen, Dehua Wu, Suming Pan and Yuwen Xie and has published in prestigious journals such as Nature Communications, Hepatology and Oncogene.

In The Last Decade

Yizhi Zhan

17 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yizhi Zhan China 13 411 241 131 126 84 18 621
Guang-Ang Tian China 13 324 0.8× 180 0.7× 166 1.3× 129 1.0× 93 1.1× 20 582
Shucai Yang China 13 509 1.2× 317 1.3× 230 1.8× 154 1.2× 95 1.1× 24 793
Miaoxin Zhu China 11 471 1.1× 316 1.3× 159 1.2× 57 0.5× 83 1.0× 16 688
Xiaoqian Jing China 19 442 1.1× 221 0.9× 185 1.4× 105 0.8× 94 1.1× 32 680
Zhihong Ai China 12 427 1.0× 275 1.1× 117 0.9× 88 0.7× 53 0.6× 23 648
Shamir Cassim France 14 407 1.0× 281 1.2× 149 1.1× 116 0.9× 104 1.2× 17 696
Peiwei Huangyang China 10 496 1.2× 280 1.2× 124 0.9× 65 0.5× 54 0.6× 10 668
Dianyun Ren China 16 419 1.0× 202 0.8× 261 2.0× 110 0.9× 141 1.7× 25 708
Shishan Deng China 13 390 0.9× 177 0.7× 135 1.0× 59 0.5× 58 0.7× 31 520

Countries citing papers authored by Yizhi Zhan

Since Specialization
Citations

This map shows the geographic impact of Yizhi Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhi Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhi Zhan more than expected).

Fields of papers citing papers by Yizhi Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizhi Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhi Zhan. The network helps show where Yizhi Zhan may publish in the future.

Co-authorship network of co-authors of Yizhi Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Yizhi Zhan. A scholar is included among the top collaborators of Yizhi Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizhi Zhan. Yizhi Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Zhengyu, Yating Hu, Ying‐Ling Liu, et al.. (2025). Caffeine enhances antitumor T-cell activity by suppressing kynurenine pathway in colorectal cancer. Nature Communications. 16(1). 5906–5906.
2.
Zhan, Yizhi, Yating Hu, Yongsheng Li, et al.. (2025). Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti‐PD‐1 immunotherapy efficacy in colorectal cancer liver metastasis. Cancer Communications. 45(10). 1203–1228. 3 indexed citations
3.
Zhang, Jinchao, Wei Liu, Yizhi Zhan, et al.. (2024). DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British Journal of Cancer. 131(2). 243–257. 5 indexed citations
4.
Xie, Yuwen, Yang Liu, Zhiyong Shen, et al.. (2024). Targeting ATM enhances radiation sensitivity of colorectal cancer by potentiating radiation-induced cell death and antitumor immunity. Journal of Advanced Research. 74. 513–530. 8 indexed citations
5.
Wei, Guangyan, Yongsheng Li, Yuechen Liu, et al.. (2024). Spermine synthase engages in macrophages M2 polarization to sabotage antitumor immunity in hepatocellular carcinoma. Cell Death and Differentiation. 32(3). 573–586. 14 indexed citations
6.
Li, Yongsheng, Zhiyong Shen, Yizhi Zhan, et al.. (2023). Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity. Gut. 72(12). 2307–2320. 78 indexed citations
7.
Zhan, Yizhi, Yuqin Zhang, Yaowei Zhang, et al.. (2023). Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2. Cell Death and Disease. 14(8). 488–488. 21 indexed citations
8.
Shen, Zhiyong, Yongsheng Li, Xiaochuang Feng, et al.. (2022). GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer. Cancer Letters. 534. 215617–215617. 30 indexed citations
9.
Zhan, Yizhi, Yuechen Liu, Yuan Fang, et al.. (2022). NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma. BMC Medicine. 20(1). 365–365. 29 indexed citations
10.
Zeng, Zhicheng, Feifei Wang, Xin Peng, et al.. (2022). HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps. Oncogene. 41(29). 3719–3731. 37 indexed citations
11.
Wang, Yongjia, Yu‐Qin Zhang, Zixuan Wang, et al.. (2022). The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis. Cell Death Discovery. 8(1). 431–431. 7 indexed citations
12.
Fang, Yuan, Yizhi Zhan, Yuwen Xie, et al.. (2021). Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC. Hepatology. 75(6). 1386–1401. 56 indexed citations
13.
Fang, Yuan, Yongsheng Li, Xiaochuang Feng, et al.. (2021). S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer. British Journal of Cancer. 125(5). 734–747. 20 indexed citations
14.
Fang, Yuan, Zhiyong Shen, Yizhi Zhan, et al.. (2019). CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nature Communications. 10(1). 3981–3981. 163 indexed citations
15.
Shen, Zhiyong, Xiaochuang Feng, Yuan Fang, et al.. (2019). POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling. Cell Death and Disease. 10(11). 863–863. 30 indexed citations
16.
Shen, Zhiyong, Yongsheng Li, Yuan Fang, et al.. (2019). SNX16 activates c‐Myc signaling by inhibiting ubiquitin‐mediated proteasomal degradation of eEF1A2 in colorectal cancer development. Molecular Oncology. 14(2). 387–406. 27 indexed citations
17.
Yu, Lu, Ye Feng, Yiyi Li, et al.. (2019). Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis. Carcinogenesis. 41(5). 678–688. 41 indexed citations
18.
Zhang, Fengjiao, Jie Ding, Yonghao Liang, et al.. (2017). Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53. Journal of Cancer. 8(16). 3318–3330. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026